BMEA

Biomea Fusion Inc. is an innovative biopharmaceutical company headquartered in Redwood City, California, focused on developing cutting-edge irreversible small molecules for the treatment of genetically defined cancers. By harnessing advanced scientific methodologies, Biomea aims to meet the significant unmet medical needs of patients with specific genetic mutations, thereby establishing itself as a leader in the field of targeted cancer therapies. With a robust clinical pipeline and a strategic focus on commercialization, Biomea is well-positioned to make a transformative impact on patient care and the oncology landscape.